Hirotada Suzuki reported that the soluble fms-like tyrosinekinase 1/placental growth factor ratio may be used to rapidly distinguish AFLP from HELLP syndrome.[11] More researches are needed to find a way to predict AFLP. This evidence concerns the gene PGF and HELLP syndrome.